|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 23, No 25 (September 1), 2005: pp. 6083-6096 © 2005 American Society of Clinical Oncology. DOI: 10.1200/JCO.2005.09.548 Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part I: Sleep and Psychological EffectsFrom the Laval University Cancer Research Center; and School of Psychology, Université Laval, Québec, Québec, Canada Address reprint requests to Josée Savard, PhD, Laval University Cancer Research Center, 11 Côte du Palais, Québec, Québec, G1R 2J6 Canada; e-mail: josee.savard{at}psy.ulaval.ca PURPOSE: Chronic insomnia is highly prevalent in cancer patients. Cognitive-behavioral therapy (CBT) is considered the treatment of choice for chronic primary insomnia. However, no randomized controlled study has been conducted on its efficacy for insomnia secondary to cancer. Using a randomized controlled design, this study conducted among breast cancer survivors evaluated the effect of CBT on sleep, assessed both subjectively and objectively, and on hypnotic medication use, psychological distress, and quality of life. PATIENTS AND METHODS: Fifty-seven women with insomnia caused or aggravated by breast cancer were randomly assigned to CBT (n = 27) or a waiting-list control condition (n = 30). The treatment consisted of eight weekly sessions administered in a group and combined the use of stimulus control, sleep restriction, cognitive therapy, sleep hygiene, and fatigue management. Follow-up evaluations were carried out 3, 6, and 12 months after the treatment. RESULTS: Participants who received the insomnia treatment had significantly better subjective sleep indices (daily sleep diary, Insomnia Severity Index), a lower frequency of medicated nights, lower levels of depression and anxiety, and greater global quality of life at post-treatment compared with participants of the control group after their waiting period. Results were more equivocal on polysomnographic indices. Therapeutic effects were well maintained up to 12 months after the intervention and generally were clinically significant. CONCLUSION: This study supports the efficacy of CBT for insomnia secondary to breast cancer. Supported in part by an operating grant (MT-14039) and salary support from the Canadian Institutes of Health Research. Results of this study have been reported in part at the 16th Annual Meeting of the Associated Professional Sleep Societies, Seattle, WA, June 2002; the 62nd Annual Convention of the Canadian Psychological Association, Québec, Québec, Canada, June 2001; the 2nd Scientific Conference on Reasons for Hope: New Developments in Breast Cancer Research, Québec, Québec, Canada, May 2001; the 6th World Congress of Psycho-Oncology, Banff, Alberta, Canada, April 2003; and the 6th International Congress of Behavioral Medicine, Brisbane, Australia, November 2000. Authors' disclosures of potential conflicts of interest are found at the end of this article. This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|